Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

43%

3 of 7 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

Phase 1

5(62.5%)

Phase 2

2(25.0%)

N/A

1(12.5%)

8Total

Phase 1(5)

Phase 2(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT04458545Phase 1Recruiting

Clinical Trials of Multivalent Opioid Vaccine Components

Role: collaborator

NCT05712707Phase 1Active Not Recruiting

Sublingual Dexmedetomidine for Treating Opioid Withdrawal

Role: collaborator

NCT03810495Phase 1Completed

The O'Neil Long Acting Naltrexone Implant (OLANI) Pharmacokinetic (PK)/Safety Study in Healthy Volunteers

Role: collaborator

NCT04251182Phase 2Completed

Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate AD Subjects

Role: collaborator

NCT04716881Phase 1Completed

Pharmacokinetic Study of Vivitrol in Healthy Participants

Role: collaborator

NCT03516305Phase 1Completed

Pharmacokinetic Study Evaluating Staccato® Alprazolam 1 mg Inhaler in Smokers Versus Non-Smokers

Role: collaborator

NCT05028764Completed

Determine Range of Tissue Frataxin Concentrations and Other Potential Biomarkers

Role: collaborator

NCT02671760Phase 2Completed

Pilot Study of a Combination Drug Product for Treatment of Short-term Insomnia

Role: collaborator

NCT00935402Not ApplicableCompleted

Sleep Deprivation and Energy Balance

Role: collaborator

All 9 trials loaded